DSP Healthcare Fund Direct - Growth
NAV
₹41.7950
as on 04 Jun 2025, 09:00 PM
₹0.2240(0.54%)
Last Change
Scheme Information
DSP Healthcare Fund Direct - Growth
as of 30 Apr 2025, 05:30 AM
₹2,912.01 Cr
0.62%
0.14%
Open-End
Growth
Exit load of 0.50% if redeemed within 1 month.
BSE Healthcare Total Return Index
View
Sectors Holding in this Mutual Fund
Healthcare
97.71%
₹2,845.32 Cr
Insurance
1.56%
₹45.43 Cr
Others
0.73%
₹21.26 Cr
Healthcare
97.71%
₹2,845.32 Cr
Insurance
1.56%
₹45.43 Cr
Others
0.73%
₹21.26 Cr
Sun Pharmaceutical Industries Ltd.
12.50%
₹364.00 Cr
Cohance Lifesciences Ltd.
9.38%
₹273.15 Cr
Cipla Ltd.
8.28%
₹241.11 Cr
Ipca Laboratories Ltd.
7.31%
₹212.87 Cr
Lupin Ltd.
7.14%
₹207.92 Cr
Others
55.39%
₹1,612.96 Cr
Sun Pharmaceutical Industries Ltd.
12.50%
₹364.00 Cr
Cohance Lifesciences Ltd.
9.38%
₹273.15 Cr
Cipla Ltd.
8.28%
₹241.11 Cr
Ipca Laboratories Ltd.
7.31%
₹212.87 Cr
Lupin Ltd.
7.14%
₹207.92 Cr
Others
55.39%
₹1,612.96 Cr
Funds in this Category
This fund's returns: 25.82%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
Min. Investment
₹100
29.03
Category Returns
18.56%
29.03%
3Y Returns
29.03 %
SBI Healthcare Opportunities Fund Direct Plan-Growth
Min. Investment
₹500
28.48
Category Returns
18.56%
29.03%
3Y Returns
28.48 %
UTI Healthcare Fund Direct-Growth
Min. Investment
₹500
26.12
Category Returns
18.56%
29.03%
3Y Returns
26.12 %
About DSP Healthcare Fund Direct - Growth
DSP Healthcare Fund Direct - Growth scheme return performance in last 1 year is 22.02%, in last 3 years is 99.41% and 315.71% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
AUM: | ₹2,912.01 Cr |
Category: | Equity: Sectoral-Pharma |
Launch Date: | Invalid date |
Fund Type: | Open-End |
AMC Information
DSP Mutual Fund
Address
Investment Performance
₹ 1,00,000
would have given a return of
₹1,10,871
₹1,21,647
₹1,91,498
₹1,99,413
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
Profit (absolute return)
₹99,413
99.41%
Investment Returns
Scheme Riskometer
Investors understand that their principal will be at very high risk